The AMPK-ALDH7A1 axis drives metabolic reprogramming and anti-tumor immunity in hepatocellular carcinoma via KDM5C inhibition

Developmental Cell · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles